[Determination of the corrective properties of midantan in disorders of rat operant activity caused by different classes of tranquilizing agent].
D000547:Amantadine / Q000494:pharmacology*; D000818:Animals; D014151:Anti-Anxiety Agents / Q000037:antagonists & inhibitors; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000037:antagonists & inhibitors; D003216:Conditioning, Operant / Q000187:drug effects*; D003975:Diazepam / Q000037:antagonists & inhibitors; D018756:GABA Antagonists; D008620:Meprobamate / Q000037:antagonists & inhibitors; D009025:Morpholines / Q000037:antagonists & inhibitors; D051381:Rats; D012978:Sodium Oxybate / Q000037:antagonists & inhibitors; D014149:Tranquilizing Agents / Q000037:antagonists & inhibitors*; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives
D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D018756:GABA Antagonists; D009025:Morpholines; D014149:Tranquilizing Agents; D001569:Benzodiazepines; C005831:trimetozine; C017928:phenazepam; D005680:gamma-Aminobutyric Acid; D012978:Sodium Oxybate; D008620:Meprobamate; D000547:Amantadine; D003975:Diazepam; C008842:4-amino-3-phenylbutyric acid
Otsenka korrektornykh svoĭstv midantana pri rasstroĭstvakh operantnoĭ deiatel'nosti krys, vyzvannykh trankvilizatorami razlichnykh grupp.